
Colin Lindsay
Dr Lindsay is a Professor of Medical Oncology at the University of Manchester, also working at the Christie NHS Foundation Trust to divide his time 50/50 between research and the clinic. He trained at the Cancer Research UK Beatson Institute and Cancer Centre in Glasgow, where he completed a PhD under Owen Sansom studying genetically-modified mouse models of RAS- and RAF-driven melanoma. Following that he shifted focus to lung cancer translation through involvement with the CRUK Stratified Medicine Programme, as well as a two year ESMO translational fellowship with Benjamin Besse and Jean-Charles Soria at the Gustave Roussy Institute in Villejuif, France. He is a past recipient of the ACP McElwain prize and the IASLC Young Investigator award. His main research interests are the translation and implementation of effective treatment strategies for cancers driven by RAS mutation and the MAPK pathway.
